Announcing Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Read UMR's Dec. 8 Letter to Congressional Leadership on the Urgent Need to Pass an FY23 Omnibus Appropriations Bill
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
NIH's Role In Sustaining the U.S. Economy | 2022 Update Now Available

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Allergies to mRNA-based COVID-19 vaccines rare, generally mild, Stanford-led study finds

Allergic reactions to the new mRNA-based COVID-19 vaccines are rare, typically mild and treatable, and they should not deter people from becoming vaccinated, according to a study led by researchers at the Stanford University School of Medicine. The findings were published online Sept. 17 in JAMA Network Open.